Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tejdip Singh"'
Autor:
Jerry Mendell, Perry Shieh, Zarife Sahenk, Kelly Lehman, Linda Lowes, Natalie Reash, Megan Iammarino, Lindsay Alfano, Brenna Sabo, Jeremy Woods, Christy Skura, Howard Mao, Loretta Staudt, Rachael Potter, Danielle Griffin, Sarah Lewis, Shufang Wang, Tejdip Singh, Louise Rodino-Klapac
Publikováno v:
Thursday, April 27.
Autor:
Crystal Proud, Craig Zaidman, Perry Shieh, Craig McDonald, John Day, Stefanie Mason, Maitea Guridi, Lixin Han, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, James Richardson, Jyoti Malhotra, Tejdip Singh, Louise Rodino-Klapac, Jerry Mendell
Publikováno v:
Thursday, April 27.
Autor:
Francesco Muntoni, Eugenio Mercuri, Ulrike Schara Schmidt, Hirofumi Komaki, James Richardson, Tejdip Singh, Maitea Guridi, Stefanie Mason, Alex Murphy, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, Jerry Mendell
Publikováno v:
Monday, April 24.
Autor:
Ingrid Boltje, Gilbert Wagener, Lisa L. von Moltke, Zhaoyang Li, Günther Pabst, Tejdip Singh, Marjie L. Hard, Grit Andersen, Wai Chin, Kerry E. Culm‐Merdek
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 52:314-320
Objectives To characterize the safety, tolerability, pharmacokinetics (PK) and dose proportionality of mipomersen after single subcutaneous (SC) administration to Japanese healthy subjects; and to compare the PK profiles of Japanese and Western subje
Autor:
Ravi S. Kamath, Ana Cristina Puga, Mathilde Kaper, Marcelo Iastrebner, Daniel I. Rosenthal, Tejdip Singh, Nora Watman, Elsa Avila Arreguin, Mici Phillips, Hanna Rosenbaum, M. Judith Peterschmitt, Elena Lukina, Gregory M. Pastores, Marta Dragosky
Publikováno v:
Blood. 116:4095-4098
Eliglustat tartrate is an investigational oral substrate reduction therapy for Gaucher disease type 1 that is pharmacologically distinct from intravenous enzyme replacement therapy. Eliglustat tartrate improved clinical manifestations in patients who
Publikováno v:
Journal of cardiovascular pharmacology. 64(2)
Mipomersen is a second-generation antisense oligonucleotide indicated as an adjunct therapy for homozygous familial hypercholesterolemia (HoFH). Warfarin is commonly prescribed for a variety of cardiac disorders in homozygous familial hypercholestero
Publikováno v:
Critical Care Medicine. 28:1439-1444
OBJECTIVE To test whether or not endotoxin induces a dose-dependent reduction of myocardial contractile dysfunction after a standardized period of myocardial ischemia and reperfusion and whether nitric oxide is involved in this form of myocardial pro
Autor:
Tejdip Singh, William J. Sibbald
Publikováno v:
Critical Care Clinics. 13:347-362
Critical care medicine in Canada has evolved into a multidisciplinary service, teaching, and research activity. Pressure on existing funding models for the delivery of health care in Canada is leading to substantial change in the hospital sector. Alt
Autor:
Nora Watman, Marta Dragosky, Marcelo Iastrebner, Tejdip Singh, M. Judith Peterschmitt, Ana Cristina Puga, Peter L. Bonate, Maryam Banikazemi, Elsa Avila Arreguin, Mathilde Kaper, Hanna Rosenbaum, Mici Phillips, Daniel I. Rosenthal, Elena Lukina, Gregory M. Pastores
Publikováno v:
Blood. 116(6)
Eliglustat tartrate (Genz-112638), a specific inhibitor of glucosylceramide synthase, is under development as an oral substrate reduction therapy for Gaucher disease type 1 (GD1). A multinational, open-label, single-arm phase 2 study of 26 GD1 patien
Autor:
Hanna Rosenbaum, Tejdip Singh, Marcelo Iastrebner, Ana Cristina Puga, Elena Lukina, Nora Watman, Marta Dragosky, Mathilde Kaper, M.J. Peterschmitt, Elsa Avila Arreguin, Mici Phillips, Gregory M. Pastores
Publikováno v:
Molecular Genetics and Metabolism. 99:S30